Currently holds positions in Ardelyx Inc, Epizyme Inc, Mersana Therapeutics Inc and Adaptimmune Therapeutics PLC
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Ardelyx Inc | March 1, 2014 - |
Independent Chairman of the Board | Epizyme Inc | April 1, 2016 - |
Independent Chairman of the Board | Mersana Therapeutics Inc | Jan. 1, 2017 - |
Non-Executive Independent Chairman of the Board | Adaptimmune Therapeutics PLC | Jan. 1, 2017 - |
Independent Chairman of the Board | TESARO Inc | July 1, 2011 - Jan. 22, 2019 |
Chairman of the Board | Mersana Therapeutics Inc | Nov. 1, 2013 - Jan. 1, 2017 |
Non-Executive Vice Chairman of the Board | Adaptimmune Therapeutics PLC | May 24, 2016 - Jan. 1, 2017 |
Non-Executive Independent Director | Adaptimmune Therapeutics PLC | Sept. 1, 2014 - May 24, 2016 |
Independent Director | Epizyme Inc | Dec. 1, 2009 - April 1, 2016 |
Director | Ardelyx Inc | March 1, 2009 - March 1, 2014 |
Chairman of the Board | Mersana Therapeutics Inc | July 1, 2012 - Nov. 1, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-17 | 2022-11-17 |
Ardelyx Inc
(ARDX)
|
B Purchase |
567,000
+94.5%
1.761,000,642 USD |
567,000 +94.5% | 1.76 | 1,000,642 USD | |
2022-02-23 | 2022-02-23 |
Imara Inc
(IMRA)
|
B Purchase |
35,257
+18.2%
1.4651,475 USD |
35,257 +18.2% | 1.46 | 51,475 USD | |
2022-02-23 | 2022-02-22 |
Imara Inc
(IMRA)
|
B Purchase |
65,817
+51.4%
1.56102,675 USD |
65,817 +51.4% | 1.56 | 102,675 USD | |
2022-02-23 | 2022-02-18 |
Imara Inc
(IMRA)
|
B Purchase |
50,398
+64.8%
1.3065,517 USD |
50,398 +64.8% | 1.30 | 65,517 USD | |
2022-02-17 | 2022-02-17 |
Imara Inc
(IMRA)
|
B Purchase |
14,595
+23.1%
1.1717,076 USD |
14,595 +23.1% | 1.17 | 17,076 USD | |
2022-02-17 | 2022-02-16 |
Imara Inc
(IMRA)
|
B Purchase |
11,779
+22.9%
1.2014,135 USD |
11,779 +22.9% | 1.20 | 14,135 USD | |
2022-02-17 | 2022-02-15 |
Imara Inc
(IMRA)
|
B Purchase |
19,552
+61.4%
1.2023,462 USD |
19,552 +61.4% | 1.20 | 23,462 USD | |
2022-02-14 | 2022-02-14 |
Imara Inc
(IMRA)
|
B Purchase |
8,500
+36.4%
1.1810,030 USD |
8,500 +36.4% | 1.18 | 10,030 USD | |
2022-02-14 | 2022-02-11 |
Imara Inc
(IMRA)
|
B Purchase |
14,573
+166.5%
1.2317,925 USD |
14,573 +166.5% | 1.23 | 17,925 USD | |
2022-02-14 | 2022-02-10 |
Imara Inc
(IMRA)
|
B Purchase |
8,753
+inf%
1.2911,291 USD |
8,753 +inf% | 1.29 | 11,291 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
B Purchase |
217
+0.1%
7.801,693 USD |
217 +0.1% | 7.80 | 1,693 USD | |
2021-03-29 | 2021-03-26 |
Epizyme Inc
(EPZM)
|
B Purchase |
34,269
+29.4%
7.97273,124 USD |
34,269 +29.4% | 7.97 | 273,124 USD | |
2021-03-29 | 2021-03-25 |
Epizyme Inc
(EPZM)
|
B Purchase |
28,231
+32.0%
7.98225,283 USD |
28,231 +32.0% | 7.98 | 225,283 USD | |
2020-12-10 | 2020-12-10 |
Ardelyx Inc
(ARDX)
|
B Purchase |
170,000
+68.7%
5.891,000,841 USD |
170,000 +68.7% | 5.89 | 1,000,841 USD | |
2020-06-26 | 2020-06-26 |
Epizyme Inc
(EPZM)
|
B Purchase |
62,019
+301.3%
16.03994,165 USD |
62,019 +301.3% | 16.03 | 994,165 USD | |
2020-06-26 | 2020-06-25 |
Ardelyx Inc
(ARDX)
|
B Purchase |
68,373
+38.2%
6.96476,040 USD |
68,373 +38.2% | 6.96 | 476,040 USD | |
2020-06-26 | 2020-06-24 |
Ardelyx Inc
(ARDX)
|
B Purchase |
72,598
+68.3%
6.75489,862 USD |
72,598 +68.3% | 6.75 | 489,862 USD | |
2020-06-24 | 2020-06-22 |
Ardelyx Inc
(ARDX)
|
B Purchase |
4,673
+4.6%
6.7531,525 USD |
4,673 +4.6% | 6.75 | 31,525 USD | |
2020-04-09 | 2020-04-07 |
Mersana Therapeutics Inc
(MRSN)
|
B Purchase |
538,599
+inf%
5.593,010,768 USD |
538,599 +inf% | 5.59 | 3,010,768 USD | |
2020-01-28 | 2020-01-24 |
Adaptimmune Therapeutics PLC
(ADAP)
|
B Purchase |
7,500,000
+62.5%
0.675,000,250 USD |
7,500,000 +62.5% | 0.67 | 5,000,250 USD | |
2019-07-24 | 2019-07-22 |
Mirum Pharmaceuticals Inc
(MIRM)
|
B Purchase |
450,000
+12.0%
15.006,750,000 USD |
450,000 +12.0% | 15.00 | 6,750,000 USD | |
2019-06-28 | 2019-06-27 |
Epizyme Inc
(EPZM)
|
S Sale |
52,473
-100.0%
12.43652,134 USD |
52,473 -100.0% | 12.43 | 652,134 USD | |
2019-06-26 | 2019-06-26 |
Epizyme Inc
(EPZM)
|
S Sale |
52,472
-50.0%
12.85674,176 USD |
52,472 -50.0% | 12.85 | 674,176 USD | |
2019-06-26 | 2019-06-25 |
Epizyme Inc
(EPZM)
|
S Sale |
52,472
-33.3%
13.31698,649 USD |
52,472 -33.3% | 13.31 | 698,649 USD | |
2019-06-25 | 2019-06-24 |
Genocea Biosciences Inc
(GNCA)
|
B Purchase |
2,857,142
+65.4%
3.509,999,997 USD |
2,857,142 +65.4% | 3.50 | 9,999,997 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
B Purchase |
1,500,000
+51.0%
10.0015,000,000 USD |
1,500,000 +51.0% | 10.00 | 15,000,000 USD | |
2019-05-13 | 2019-05-09 |
Trevi Therapeutics Inc
(TRVI)
|
B Purchase |
1,000,000
+51.6%
10.0010,000,000 USD |
1,000,000 +51.6% | 10.00 | 10,000,000 USD | |
2019-05-09 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
B Purchase |
1,136,704
+124.1%
1.081,227,640 USD |
1,136,704 +124.1% | 1.08 | 1,227,640 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
4,347,827
+20.8%
1.144,956,523 USD |
4,347,827 +20.8% | 1.14 | 4,956,523 USD | |
2019-03-06 | 2019-03-05 |
Mersana Therapeutics Inc
(MRSN)
|
B Purchase |
3,750,000
+46.1%
4.0015,000,000 USD |
3,750,000 +46.1% | 4.00 | 15,000,000 USD | |
2019-02-19 | 2019-02-14 |
Genocea Biosciences Inc
(GNCA)
|
B Purchase |
9,948,269
+39.8%
0.474,688,619 USD |
9,948,269 +39.8% | 0.47 | 4,688,619 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
300,000
+1.5%
1.49448,380 USD |
300,000 +1.5% | 1.49 | 448,380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
200,000
+1.0%
1.63326,060 USD |
200,000 +1.0% | 1.63 | 326,060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
61,200
+0.3%
1.98121,084 USD |
61,200 +0.3% | 1.98 | 121,084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
26,000
+0.1%
1.9851,576 USD |
26,000 +0.1% | 1.98 | 51,576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
117,100
+0.6%
1.98232,362 USD |
117,100 +0.6% | 1.98 | 232,362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
27,300
+0.1%
1.9954,414 USD |
27,300 +0.1% | 1.99 | 54,414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
71,900
+0.4%
1.98142,067 USD |
71,900 +0.4% | 1.98 | 142,067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
24,500
+0.1%
1.9948,824 USD |
24,500 +0.1% | 1.99 | 48,824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
170,000
+0.9%
1.98336,107 USD |
170,000 +0.9% | 1.98 | 336,107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
510,000
+2.6%
1.88956,658 USD |
510,000 +2.6% | 1.88 | 956,658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
350,000
+1.8%
1.86649,355 USD |
350,000 +1.8% | 1.86 | 649,355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
340,000
+1.8%
1.86631,958 USD |
340,000 +1.8% | 1.86 | 631,958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
663,716
+3.7%
2.261,499,998 USD |
663,716 +3.7% | 2.26 | 1,499,998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
50,600
+0.3%
2.00101,165 USD |
50,600 +0.3% | 2.00 | 101,165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
200,000
+1.1%
1.95390,580 USD |
200,000 +1.1% | 1.95 | 390,580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
187,130
+1.1%
2.10392,692 USD |
187,130 +1.1% | 2.10 | 392,692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
5,295
+0.0%
2.1511,384 USD |
5,295 +0.0% | 2.15 | 11,384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
275
+0.0%
2.15591 USD |
275 +0.0% | 2.15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
32,200
+0.2%
2.1469,059 USD |
32,200 +0.2% | 2.14 | 69,059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
20,100
+0.1%
2.1442,928 USD |
20,100 +0.1% | 2.14 | 42,928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
184,179
+1.1%
2.13391,436 USD |
184,179 +1.1% | 2.13 | 391,436 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
70,873
+0.4%
2.13151,250 USD |
70,873 +0.4% | 2.13 | 151,250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
203,200
+1.2%
2.46499,994 USD |
203,200 +1.2% | 2.46 | 499,994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
32,100
+0.2%
2.4378,099 USD |
32,100 +0.2% | 2.43 | 78,099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
685,676
+4.2%
2.241,536,943 USD |
685,676 +4.2% | 2.24 | 1,536,943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
6,000,000
+57.9%
0.503,000,000 USD |
6,000,000 +57.9% | 0.50 | 3,000,000 USD |